A detailed history of Parallax Volatility Advisers, L.P. transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Parallax Volatility Advisers, L.P. holds 10,000 shares of BMEA stock, worth $71,100. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,000
Previous 10,455 4.35%
Holding current value
$71,100
Previous $47,000 114.89%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$4.23 - $10.1 $1,924 - $4,595
-455 Reduced 4.35%
10,000 $101,000
Q2 2024

Aug 14, 2024

BUY
$4.14 - $15.3 $43,283 - $159,961
10,455 New
10,455 $47,000

Others Institutions Holding BMEA

About Biomea Fusion, Inc.


  • Ticker BMEA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,290,600
  • Market Cap $208M
  • Description
  • Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...
More about BMEA
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.